PROGRAM

Conference

Check

List
May 9 (Thu) 13:30~17:15, Rm.300
Co-Located 6. Swedish Innovative Bio-Pharma Seminar
Bridging Biopharma Frontiers
   Swedish Innovative Bio-Pharma Seminar is to promote cooperation between the pharmaceutical industry in South Korea and Sweden during BioKorea 2024. Sweden is leading the global biopharmaceutical market with innovations in research and development (R&D) fields such as telemedicine, precision medicine, and medical engineering based on its strong life science history. In this seminar, eight Swedish companies and institutions with innovative technologies will introduce Swedish biopharmaceutical industry trends and introduce their respective pipelines and services. This event will contribute to promoting innovation and growth in the biopharmaceutical industry in both countries.
  • Session Chair
  • Jaeyeon Lee Consultant, Invest, Swedish Trade & Invest Council
  • Welcoming Remarks
  • Lars HammarströmScience & Innovation Counsellor, Office of Science & Innovation, Embassy of Sweden in Korea
  • 13 : 30 ~ 13 : 35
  • SwedenBIO – the gateway to the Swedish Life Science Industry
  • Marjo PuumalainenInternational Director, SwedenBIO
  • 13 : 35 ~ 13 : 40
  • CCRM Nordic - a National Infrastructure for Commercialization of Advanced Therapies
  • Jim LundCBDO, CCRM Nordic
  • 13 : 40 ~ 14 : 00
  • Your Preferred Partner for Neurology in Vitro Research
  • Mattias KarlssonCEO, Cellectricon
  • 14 : 00 ~ 14 : 20
  • Novel Inhalers and Powder Formulations - ICONOVO - A Complete Partner in Development of Inhalation Products
  • Johan WaborgCEO, Iconovo AB
  • 14 : 20 ~ 14 : 40
  • Accelerating Drug Development with Proteomics: De-Risking Through True Insights
  • Wen Jing SimSales Director, Business Development, Olink Proteomics
  • 14 : 40 ~ 15 : 00
  • Q&A
  • 15 : 05 ~ 15 : 20
  • Discovery at The Melting Point: CETSA® by Pelago Bioscience
  • Stina LundgrenHead of Business Development, Pelago Bioscience
  • 15 : 20 ~ 15 : 40
  • Unlocking Challenging Membrane Protein Drug Targets for The Development of Next-Generation Therapeutics.
  • Lorena Galán AcostaBusiness Development Manager, Salipro Biotech AB
  • 15 : 40 ~ 16 : 00
  • SVF Vaccines: Development of a Targetted Immunotherapy to Cure chronic Hepatitis B
  • Richard BethellCEO, SVF Vaccines AB
  • 16 : 00 ~ 16 : 20
  • Q&A
  • 16 : 20 ~ 16 : 40
  • Business and Collaboration Opportunities in West Sweden
  • Iris OhrnInvestment Advisor, Establishment and Investment, Business Region Göteborg
  • 16 : 40 ~ 16 : 45
  • Lucky Draw and Closing
  • 16 : 50 ~ 17 : 00
 

BIO KOREA 2024 PARTNERS

BIO KOREA 2024 SPONSORS